Market Overview

ICYMI: MicroCap Trading Ideas, Puma Biotech, A Valeant Bear Call

Share:
ICYMI: MicroCap Trading Ideas, Puma Biotech, A Valeant Bear Call
Related VRX
Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates
TD Ameritrade Traders Adopt Some Old And New Approaches To The Trade War Market In June's IMX
Related VUZI
Chardan Stays Bullish On Vuzix After Q2 Print
50 Biggest Movers From Yesterday

In case you missed it, here are some of Benzinga's top stories from Wednesday, Jan. 24, 2018.

A Pharma Trade From Goldman

Jayson Derrick outlines a bull and bear call on Catelent, Inc (NYSE: CTLT) and Valeant Pharmaceuticals International, Inc (NYSE: VRX), respectively, from Goldman Sachs. Check out “Goldman Sachs On Specialty Pharma: Buy Catalent, Sell Valeant.”

Puma Biotech Declawed By European Medicines Agency

Puma Biotechnology, Inc (NASDAQ: PBYI) shares were crushed Wednesday after reporting a negative trend vote from European regulators regarding its neratinib compound. Learn more in Shanthi Rexaline’s “What You Need to Know About Puma Biotech's 25% Slide.”

Related Link: With EU Approval For Puma Biotech's Breast Cancer Drug Unlikely, Cowen Downgrades

'3 Micro-Cap Tech Stocks To Watch In 2018'

Bill Haddad checked out the LD Micro Virtual CES Wrap Up so that you don’t have to. From Vuzix Corporation (NASDAQ: VUZI) to My Size, Inc (NASDAQ: MYSZ), learn why these names are worth keeping an eye on this year.

Latest Ratings for VRX

DateFirmActionFromTo
Jun 2018TD SecuritiesDowngradesBuyHold
Jun 2018BarclaysUpgradesEqual-WeightOverweight
May 2018MizuhoUpgradesNeutralBuy

View More Analyst Ratings for VRX
View the Latest Analyst Ratings

Posted-In: Analyst Color Biotech News Previews Small Cap After-Hours Center Analyst Ratings Trading Ideas Best of Benzinga

 

Related Articles (CTLT + MYSZ)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
BAPItau BBAUpgrades274.0
DVNJP MorganDowngrades37.0
EOGJP MorganUpgrades118.0
EQMBarclaysDowngrades48.0
EXPDGoldman SachsDowngrades68.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

11 Stocks Moving In Wednesday's After-Hours Session

Michigan Gov. Rick Snyder, Autobooks CEO Talk Detroit Startup Culture